Search
for
Sort by
Research 511–540 of 1000+
- Prediction and Demonstration of Retinoic Acid Receptor Agonist Ch55 as an Antifibrotic Agent in the Dermis
- OA08 Ocrelizumab in pregnancy in a patient with juvenile onset systemic lupus erythematosus
- Referee report. For: Case Report: Tuberculosis lymphadenitis with systemic lupus erythematosus in a young woman: a case report [version 2; peer review: 2 approved, 1 not approved]
- Referee report. For: Case Report: Tuberculosis lymphadenitis with systemic lupus erythematosus in a young woman: a case report [version 2; peer review: 1 approved, 1 approved with reservations, 1 not approved]
- Referee report. For: Case Report: Tuberculosis lymphadenitis with systemic lupus erythematosus in a young woman: a case report [version 1; peer review: 2 approved with reservations, 1 not approved]
- Referee report. For: Case Report: Tuberculosis lymphadenitis with systemic lupus erythematosus in a young woman: a case report [version 1; peer review: 2 approved with reservations]
- COVID-19: How Effective Are the Repurposed Drugs and Novel Agents in Treating the Infection?
- Beyond the Follicle: A Narrative Review on How Systemic Diseases and Drugs Affect Alopecia
- Development of Provesicular Nanodelivery System of Curcumin as a Safe and Effective Antiviral Agent: Statistical Optimization, In Vitro Characterization, and Antiviral Effectiveness
- Fullerene C<sub>60</sub> with cytoprotective and cytotoxic potential: prospects as a novel treatment agent in Dermatology?
- Thiazole: A Versatile Standalone Moiety Contributing to the Development of Various Drugs and Biologically Active Agents
- Specificity of anti-SSB as a diagnostic marker for the classification of systemic lupus erythematosus
- Chitosan Nanoparticles for Topical Drug Delivery in Chemotherapy-Induced Alopecia: A Comparative Study of Five Repurposed Pharmacological Agents
- P47 Condition overlay and diagnostic delay – A challenging case of fibromyalgia and systemic lupus erythematosus
- Efficacy of bergamot: From anti‐inflammatory and anti‐oxidative mechanisms to clinical applications as preventive agent for cardiovascular morbidity, skin diseases, and mood alterations
- Androgenetic alopecia - just a cosmetic defect or a biomarker and risk factor for systemic diseases? - literature review
- Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy
- Aggressive treatment in paediatric or young patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with future development of type III polyglandular autoimmune syndrome
- Platinum-Induced Peripheral Neuropathy (PIPN): ROS-Related Mechanism, Therapeutic Agents, and Nanosystems
- Epidermal Growth Factor Receptor Inhibitor–Induced Symmetrical Drug-Related Intertriginous and Flexural Exanthema: Should You Discontinue the Offending Agent?
- ZnO@PDA@Ag Nanocomposite-Mediated Delivery of 9-Bromonoscapine, an Anticancer Agent, for Enhanced Lung Cancer Therapy
- Shrimp-derived extracts as antibacterial, antioxidant, and burn wound-healing agents: Comprehensive in vitro and in vivo evaluation from Yemeni coastal resources.
- Isolated hyperthermic chemotherapy perfusion for limb melanoma is a safe procedure
- Cutaneous lupus erythematosus: a review
- Transfollicular drug delivery—Is it a reality?
- Tobacco and the skin
- Autoimmune Disease and Hair Loss
- Update on the Treatment of Alopecia Areata
- Dermatologic Diseases
- Dermatological medications and local therapeutics